Table 1.
Demographics and Baseline Characteristics
| N = 244 | |
|---|---|
| Age, mean (SD), y | 30.4 (14.0) |
| Male, n (%) | 139 (57) |
| Body weight, mean (SD), kg | 69.6 (21.6) |
| Ointment dose, median (range), mg | 16 500 (4800‐47 100) |
| Disease condition, n (%) | |
| Healthy | 154 (63) |
| Atopic dermatitis | 57 (23) |
| Mild (ISGA 2) | 25 (44) |
| Moderate (ISGA 3) | 32 (56) |
| Psoriasis | 33 (14) |
| Moderate (PGA 2 or 3) a | 22 (67) |
| Severe (PGA 4 or 5)b | 11 (33) |
| Race/ethnicity, n (%) | |
| White | 184 (75) |
| Black | 30 (12) |
| Latino | 17 (7) |
| Other | 13 (5) |
ISGA indicates Investigator's Static Global Assessment; PGA, Physician's Global Assessment.
a
A PGA score of 2 is characterized as mild but for this analysis was combined with a score of 3 and categorized as moderate. Overall, there were 3 patients with a PGA score of 2 and 19 patients with a PGA score of 3.
bA PGA score of 5 is characterized as very severe but for this analysis was combined with a score of 4 and categorized as severe. Overall, there were 9 patients with a PGA score of 4 and 2 patients with a PGA score of 5.